🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Stocks jump on media reports of drug breakthroughs for coronavirus: traders

Published 02/05/2020, 04:17 AM
Updated 02/05/2020, 04:21 AM
© Reuters.  Stocks jump on media reports of drug breakthroughs for coronavirus: traders
EUR/CHF
-
STOXX
-

LONDON (Reuters) - European stocks jumped sharply on reports that a Chinese university found a drug to treat people with the new coronavirus and researchers in the UK saying they made a "significant breakthrough" in finding a vaccine, several London-based traders said.

A scientist leading UK's research into a coronavirus vaccine told Sky https:// news that his team have made a "significant breakthrough" by reducing a part of the normal development time from two to three years to just 14 days.

Meanwhile, traders also cited a Chinese TV report that a research team at Zhejiang University has found an effective drug to treat people with the new coronavirus sharp for a rise in stocks.

Reuters has not verified those media reports, but several traders have attributed the sharp move in markets to the reports.

The benchmark pan-European STOXX 600 (STOXX) index, which started the day on the backfoot, reversed early losses and rose as much as 0.8% on day.

U.S. stock futures also turned positive, rising 0.5%.

"Equity markets in Europe have had a sharp turnaround on the back of unconfirmed reports," said David Madden, market analyst at CMC Markets UK.

"Traders have taken the view that the situation is now more likely to be under control and hopefully the spread of the health crisis will be stemmed and it hopefully leads to a return to normality in China and around the world."

In the forex market, riskier currencies including the Australian dollar climbed 0.3% at $0.6758. The Swedish crown hit a near two-week high at 9.56 crowns per dollar while the euro/Swiss franc (EURCHF=EBS) exchange rate, a barometer of risk sentiment, strengthened.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.